Monoallelic TP53 mutations frequently have co-mutations in other genes, mostly TET2, SF3B1, ASXL1, and DNMT3A, and are likely to be subclonal events with varying impacts on outcomes of MDS/AML [23]. Here, TP53 is linked to acute myeloid leukemia.